Evidence map›Paper›PMID 37327376›Full record

ReviewBrain : a journal of neurology2023

Skeletal muscle in amyotrophic lateral sclerosis.

Jeremy M Shefner, Antonio Musaro, Shyuan T Ngo, Christian Lunetta, Frederik J Steyn, Richard Robitaille, Mamede De Carvalho, Seward Rutkove, Albert C Ludolph, Luc Dupuis

Open access · hybridAbstract readReview
In one paragraph

Review in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Metabolic Brain Disorders: Prodromes, Symptoms, and Syndromes.International journal of molecular sciences · 2026
    Review
  15. Article
  16. Article
  17. Systemic brain-body metabolic coupling patterns in amyotrophic lateral sclerosis: a whole-body [European journal of nuclear medicine and molecular imaging · 2026
    Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 7 countries.

Jeremy M ShefnerBarrow Neurological Institute, Phoenix, AZ, USA.
Antonio MusaroDAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Scuola Superiore di Studi Avanzati Sapienza (SSAS), Rome, Italy.
Shyuan T NgoAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia.
Christian LunettaNeurorehabilitation Department, Istituti Clinici Scientifici Maugeri IRCCS, Milan, Italy.
Frederik J SteynBiomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Australia.ORCID 0000-0002-4782-3608
Richard RobitailleDépartement de neurosciences, CIRCA, Université de Montréal, Montréal H7G 1T7, Canada.
Mamede De CarvalhoInstituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Seward RutkoveBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Albert C LudolphDepartment of Neurology, University of Ulm, Ulm, Germany.
Luc DupuisUniversité de Strasbourg, Inserm, UMR-S1118, Mécanismes centraux et périphériques de la neurodégénérescence, CRBS, Strasbourg, France.ORCID 0000-0002-0902-5824
The University of Queensland · AUBeth Israel Deaconess Medical Center · USCreighton University · USInserm · FRIstituti Clinici Scientifici Maugeri · ITIstituto Pasteur · ITUniversität Ulm · DEUniversité de Montréal · CAUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS), the major adult-onset motor neuron disease, has been viewed almost exclusively as a disease of upper and lower motor neurons, with muscle changes interpreted as a consequence of the progressive loss of motor neurons and neuromuscular junctions. This has led to the prevailing view that the involvement of muscle in ALS is only secondary to motor neuron loss. Skeletal muscle and motor neurons reciprocally influence their respective development and constitute a single functional unit. In ALS, multiple studies indicate that skeletal muscle dysfunction might contribute to progressive muscle weakness, as well as to the final demise of neuromuscular junctions and motor neurons. Furthermore, skeletal muscle has been shown to participate in disease pathogenesis of several monogenic diseases closely related to ALS. Here, we move the narrative towards a better appreciation of muscle as a contributor of disease in ALS. We review the various potential roles of skeletal muscle cells in ALS, from passive bystanders to active players in ALS pathophysiology. We also compare ALS to other motor neuron diseases and draw perspectives for future research and treatment.

Indexed as

Amyotrophic Lateral SclerosisAdultHumansMotor NeuronsMuscle, SkeletalMuscle WeaknessNeuromuscular Junctiondenervationenergy metabolismmouse modelsneuromuscular junctionneurophysiology

Identifiers

PMID37327376
PMCPMC10629757
OpenAlexW4380875394

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.